MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 45 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,429 | -60.5% | 59,846 | 0.0% | 0.00% | – |
| Q2 2023 | $89,769 | -13.1% | 59,846 | -0.4% | 0.00% | – |
| Q1 2023 | $103,355 | +62.4% | 60,090 | +8.6% | 0.00% | – |
| Q4 2022 | $63,659 | -55.8% | 55,356 | 0.0% | 0.00% | – |
| Q3 2022 | $144,000 | +22.0% | 55,356 | +2.2% | 0.00% | – |
| Q2 2022 | $118,000 | -53.2% | 54,151 | 0.0% | 0.00% | – |
| Q1 2022 | $252,000 | -26.5% | 54,151 | -4.3% | 0.00% | – |
| Q4 2021 | $343,000 | -15.7% | 56,561 | 0.0% | 0.00% | – |
| Q3 2021 | $407,000 | +180.7% | 56,561 | +145.4% | 0.00% | – |
| Q2 2021 | $145,000 | – | 23,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 309,178 | $671,000 | 0.14% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
| Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
| Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
| M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
| Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
| Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |